University of Florida, USA
Posters & Accepted Abstracts: J Psychiatry
This session will begin with an overview of the DSM-V criteria for Avoidant/Restrictive Food Intake Disorder (ARFID) and a review of the latest research on this “new” diagnosis. We will take a closer look at differential diagnosis and highlight possible symptom overlap of ARFID with anorexia nervosa and other eating disorders, anxiety, obsessive compulsive disorder and sensory processing disorder. We will summarize recent findings on etiology and prevalence rates for ARFID and present in-depth case studies (including recorded interviews with the adolescent male patient and an adult female) to illustrate the characteristic presentation of this disorder. Following the case study we will discuss multi-disciplinary treatment approaches and modalities for ARFID including medical management, nutrition therapy, dialectical behavior therapy, exposure and response prevention, mindfulness, expressive arts therapies and family therapy. Focus will be given to looking at the use of exposure-response prevention (ERP), a modality that is frequently effective for the treatment of anxiety disorder, on ARFID. Participants will have an opportunity to ask questions and participate in discussion. This session will take a closer look at Avoidant/Restrictive Food Intake Disorder (ARFID), one of the "new" eating disorders in DSM-5, exploring etiology, epidemiology and multidisciplinary treatment, comparing with other eating disorder diagnoses. Teaching methods will include in-depth case studies, to include patient videos. We will present research data on the use of exposure response prevention (ERP), a behavioral treatment modality that is very effective in treating anxiety disorders, on ARFID. This is based on the observation that some ARFID patients have a significant anxiety component with their food aversion. Three measurable learning objectives of the presentation: Identify 3 distinguishing characteristics of ARFID describe 3 common challenges in treatment of ARFID and explain rationale for Exposure and Response Prevention (ERP) treatment modality.
Email: [email protected]